chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt states on the night of the vaccine she started experiencing swelling of the left deltoid, redness, pain, and it was hot to touch. she also states she had fever. Pt states he took advil and put aloe vera on the left arm which help her with the pain, swelling and redness. Pt came to pharmacy today 05/10/2023 and the redness from left deltoid is still visible, which she states putting aloe vera on helps.
Mo gave APAP on arriving home then 2 hrs later had high fever took to ER-t102.2 given APAP;
Client was given DTaP-should have been given Tdap. Not licensed for this age.
I developed blisters all over the inside of my mouth after getting the first dose of my vaccine. They are especially painful on the tip of my tongue and on the roof of my mouth. My mouth is raw, and the problem has persisted for ten months. I have lost 35 pounds because I am limited to a soft diet. I also experienced much more severe migraines after getting my vaccine. The pain was so bad that I went to the urgent care. Have had to add some medication. I used to get migraines all the time, but the pain was more manageable. I have been diagnosed with chronic migraines since I got my vaccine.
No further AE details; Improper storage of product in use; This spontaneous report was received from a pharmacist and refers to an 11-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 02-MAR-2023, varicella virus vaccine live (oka/merck) (VARIVAX) was underwent temperature excursion at 70 Fahrenheit degrees (F) for 9 minutes. On 09-JUN-2023, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5ml/once, lot #W025273, expiration date not reported, but upon internal validation established as: 10-AUG-2024, administered for prophylaxis (anatomical location, and route of administration were not provided). It was also reported another lot # W0252273 with expiration date: 02-JUN-2023, but it is an invalid lot # for varicella virus vaccine live (oka/merck) (VARIVAX), and also the registered nurse stated that this lot # was incorrect (product storage error).  There were no adverse events reported (no adverse event).  This is one of several reports received from the same reporter.
Had febrile seizure. Was taken by ambulance to hospital for febrile seizure.
My symptoms of COVID were generally mild.  I had a cough, loose stools, a minor fever of about 99.8 degrees for a day.  I had a very runny nose.  I received Paxlovid for the first dose I took the evening I tested positive.  I took it for 5 days.  I continued to test positive until the 8th day.  I have had no other effects that I am aware of to this point.
Estimated date of delivery is 8/23/21. Patient was admitted on 6/28/2021 for painful contractions and increased pelvic pressure. She was diagnosed with pre-term delivery. Patient was tested following the hospital's admission protocol. Patient was asymptomatic at the time of testing. This the is mother's 3rd pregnancy. She has a history of pre-term contractions with previous deliveries. No concerns noted about the fetus. Fetal movement and monitoring are normal.
Patient given the wrong vaccine: Trumenba. She should have been given Menactra due to age. No adverse reaction.
Patient came in on 10/4/11 with severe bruising from below injection site to elbow. Patient returned one week later for antibiotic prescription and arm sling.
the area itches; scratches; severe pain down her back; severe case of shingles; rash larger than the palm of her hand; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 252N2, expiry date 8th March 2022) for prophylaxis.   On 15th November 2019, the patient received the 1st dose of Shingrix (intramuscular). On 15th November 2019, less than a day after receiving Shingrix, the patient experienced shingles. On 18th November 2019, the patient experienced back pain and rash. On an unknown date, the patient experienced pruritus and scratch. The patient was treated with CORTISONE (NON-PROPRIETARY) (CORTISONE CREAM). On an unknown date, the outcome of the shingles and scratch were unknown and the outcome of the back pain and pruritus were not recovered/not resolved and the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the shingles, back pain, rash, pruritus and scratch to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix and developed severe pain down her back, on the side she received the injection. She also had a rash larger than the palm of her hand in the area where she had pain. She saw her health care professional and was told to put cortisone cream on the rash, but it did not do anything.  The pain was at level 10 for 2-3 weeks, and it has continued, though less severe since. The rash finally resolved about 1 month ago. The pain was always preset at level 3-4. Sometimes the area itches and if she scratches it the pain would flare up more severely. The reporter told if her clothes rub on the area the pain also flares up.  The reporter stated that this has been a severe case of shingles. The reporter consented to follow up. Emergency room visit required.
Redness, soreness, warm to touch, large amount of swelling at site for about 1 week, continue to have deep pain and soreness in arm especially after laying on arm, acquired covid 12/28/21 and now have long Covid symptoms
fatigue, insomnia, pain in small joints, brain fog, increased blood pressure, kidney damage, myocarditis,
body aches; left arm was sore; nose was kind of inflamed; the rest of her was feeling real warm; Her feet was feeling cold; This spontaneous case was reported by a consumer and describes the occurrence of NASAL DISCOMFORT (nose was kind of inflamed), FEELING HOT (the rest of her was feeling real warm), PERIPHERAL COLDNESS (Her feet was feeling cold), MYALGIA (body aches) and VACCINATION SITE PAIN (left arm was sore) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033FHH) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, the patient experienced NASAL DISCOMFORT (nose was kind of inflamed), FEELING HOT (the rest of her was feeling real warm), PERIPHERAL COLDNESS (Her feet was feeling cold) and VACCINATION SITE PAIN (left arm was sore). On an unknown date, the patient experienced MYALGIA (body aches). On 04-Dec-2021, NASAL DISCOMFORT (nose was kind of inflamed), FEELING HOT (the rest of her was feeling real warm), PERIPHERAL COLDNESS (Her feet was feeling cold) and VACCINATION SITE PAIN (left arm was sore) had resolved. At the time of the report, MYALGIA (body aches) had resolved.            No concomitant medications were reported.  Treatment information was not provided. Patient had no side effects to the first 2 Moderna vaccines.   Most recent FOLLOW-UP information incorporated above includes: On 07-Dec-2021: Non Significant Follow up, contains no new information. On 07-Dec-2021: Follow up received contains Reporter information, patient details and new events Nasal discomfort, Feeling hot and Peripheral coldness were added.
OCT95 pt exp unusual pains in hands & wrist & paresthesias & arthralgias in both extremities;pain was so bad couldn't tie belt on robe;devel redness & burning in eyes in 1995;had allergy; vax may have affected immune system;
Information has been received from a physician concerning a 12 year old female patient who on 24-MAR-2007 was vaccinated with a second dose of Gardasil. On 26-MAR-2007 the patient developed a rash around the genital area and vaginal itch. It was unknown whether the physician plan to administer the third dose. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
Sweating; Pain behind the knees; Pain from Sternum to Pelvis; Pain under the mandible; swelling on the deltoid muscle,under the arm and mandible; Pain on the injection site; cervical lymphadenopathy; Chills; This spontaneous case was reported by a health care professional and describes the occurrence of SWELLING (swelling on the deltoid muscle,under the arm and mandible), INJECTION SITE PAIN (Pain on the injection site), LYMPHADENOPATHY (cervical lymphadenopathy), CHILLS (Chills) and HYPERHIDROSIS (Sweating) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Injury (Cervical injury few years ago on the left side). Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ZINC and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced SWELLING (swelling on the deltoid muscle,under the arm and mandible), INJECTION SITE PAIN (Pain on the injection site), LYMPHADENOPATHY (cervical lymphadenopathy), CHILLS (Chills), PAIN (Pain behind the knees), PAIN (Pain from Sternum to Pelvis) and PAIN (Pain under the mandible). On 02-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Apr-2021, SWELLING (swelling on the deltoid muscle,under the arm and mandible), INJECTION SITE PAIN (Pain on the injection site), LYMPHADENOPATHY (cervical lymphadenopathy), PAIN (Pain behind the knees), PAIN (Pain from Sternum to Pelvis) and PAIN (Pain under the mandible) had resolved. At the time of the report, CHILLS (Chills) and HYPERHIDROSIS (Sweating) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a elderly male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. In 2018, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient was the caller's husband, he developed flu like symptoms after his first SHINGRIX dose. This case has been linked with case US2018136199, US2018136201 and US2018136205.
Patient is complaining about nerve pain in deltoid area of right arm.  States never had reactions to prior flu shots. Paperwork indicate shot was given in left arm.
Pt. said she'd never received Hep B series.  I though I checked her imm. record.  When I went to chart it I saw she had the series in 2000+2001.  I reported this to pt, doctor, and others.
Pt with complaints of tenderness at sight of injection and difficulty lifting arm (right) for 3 weeks. No treatment sought.
Dizzy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) and FATIGUE (Tired) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (SUBOXONE), OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]), ALUMINIUM HYDROXIDE, MAGNESIUM TRISILICATE, SODIUM ALGINATE (PEPCID [ALUMINIUM HYDROXIDE;MAGNESIUM TRISILICATE;SODIUM ALGINATE]), ARIPIPRAZOLE, BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) and GABAPENTIN for an unknown indication.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced DIZZINESS (Dizzy) and FATIGUE (Tired). At the time of the report, DIZZINESS (Dizzy) and FATIGUE (Tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Expired Havrix administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (batch number unknown, expiry date September 2022) for prophylaxis.   On 2nd November 2022, the patient received Havrix. On 2nd November 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 3-Nov-2022 The called had very limited information, as they were not at the office.  The caller was asked to call back in once at the office, to provide Lot for expired vaccine and patient demos. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Havrix, which led to expired vaccine used.
Left upper arm edematous.  Swelling from elbow almost to shoulder.  Better today than yesterday (01/13/2006).
Soreness and swelling at site of injection   4 hrs  after injection  Chills one day after vaccine Joint pain one day after vaccine Fatigue  one day after vaccine Foggy, light headed feeling one day after vaccine Headache and fatigue day 2 after vaccine
My 71-year-old husband received the shingles vaccine on January 19, 2017 at the pharmacy. About 5 days later, chicken pox broke out all over his chest and back. Gradually the breakout spread to his lower back and legs, all the time accompanied by severe itching and discomfort which still continues now in late February. In addition, about two weeks ago at the beginning of February about a half dozen spots appeared on my abdomen and this week they are clearly appear as chicken pox with the stinking sensation of shingles, which I recognize because I had shingles when I was 19. I had the shingles vaccine probably a year ago but this did not prevent my catching this outbreak-albeit it small-from my husband.
Slight numbness on the left side of my face, starting somewhere around a half an hour to an hour after injection. It is now 28 hours after receiving the vaccine and the numbness is still present but milder than this time yesterday. Additionally, there was a very slight sensation of tightness in my throat that has almost completely subsided.
Rash (redness)  on palms that occurred approximately 5 hours after vaccine.  Benadryl 25 mg given at 412 pm
Patient received 6-11 year old monovalent Moderna vaccine when she should have received 12+ bivalent Moderna booster. Patient left the clinic feeling well, and without any apparent adverse reaction.
Patient reported that approximately 5 hours after receiving vaccine that her arm was sore and she developed a fever up to 100.9 with chills and shivering.  She reported that the next day she was okay and the fever broke but she was very scared of her reaction.
arm hurt where she couldn't lay or roll over on her arm; arm hurt where she couldn't lay or roll over on her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt where she couldn't lay or roll over on her arm) and HYPOKINESIA (arm hurt where she couldn't lay or roll over on her arm) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt where she couldn't lay or roll over on her arm) and HYPOKINESIA (arm hurt where she couldn't lay or roll over on her arm). At the time of the report, PAIN IN EXTREMITY (arm hurt where she couldn't lay or roll over on her arm) and HYPOKINESIA (arm hurt where she couldn't lay or roll over on her arm) outcome was unknown. Not Provided
Ten minutes after patient received vaccine, patient parents informed the pharmacy that he was not feeling well. Patient was visibly sweating, holding his stomach and then started vomiting. Father then informed the pharmacy that the patient had experienced vomiting after a previous vaccine but had cleared it with pediatrician to get the COVID vaccine. After several minutes patient stated he was feeling better and left accompanied by parents.
Information has been received from the authors in a published literature article title as stated above and refers a retrospective pregnancy report and concerns to 145 female pregnant patients of unknown ages. The patient's current conditions or medical history were not reported. On unknown date, between 01-JUN-2006 and 31-DEC-2013, the patients were vaccinated with a dose of GARDASIL (dose numbers, route, anatomical location, lot numbers and expiration dates were not reported). All patients were pregnant at the time of vaccination, Last menstrual period, (LMP), estimated conception date and estimated due date were not reported. This review of VAERS reports comprising more than 6 years of monitoring found no safely concern among pregnant women or their infants who received this vaccine during pregnancy. This is one of several cases from the same literature (1412USA011729 and 1412USA011730). A copy of the published article is attached as further documentation of the patient's experience. Additional information has been requested.
HBV-06/26/02 RLT. 06/30/02, mom called regarding infected bug bite to leg 1:40pm. 06/30/02, 6:18pm ER dx cellulitis.abscess right lateral thigh around the area where HBV vaccine given. Child also has some infected area lower right leg.
Patient experienced shoulder pain in arm of injection site- has improved throughout the day. He awoke at 4:30 am on the 3rd of July with the pain.  Also, patient noted experiencing a shock or zapping pain which lasted for about 10 seconds and would resolve behind both ears and back of neck.
Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727), via an unspecified route of administration in the right arm on 19Mar2021 at 16:00 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), ramipril (MANUFACTURER UNKNOWN), diltiazem (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN), all from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021 at 12:00, the patient experienced tinnitus. The adverse event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether the therapeutic measures were taken as a result of the adverse event. The clinical outcome of the event tinnitus was not resolved.   No follow-up attempts are needed. No further information is expected.
arthritis is intensified; back arthritis feels discomfort; soreness and injection site; Knee arthritis feels discomfort; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Apr-2021 and was forwarded to Moderna on 21-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (arthritis is intensified), MUSCULOSKELETAL DISCOMFORT (back arthritis feels discomfort), VACCINATION SITE PAIN (soreness and injection site) and MUSCULOSKELETAL DISCOMFORT (Knee arthritis feels discomfort) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002CIA) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis multiple joint and Glaucoma. Concomitant products included AMLODIPINE, LISINOPRIL, THYROID, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) and 2 glaucoma eye drops for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced ARTHRITIS (arthritis is intensified), MUSCULOSKELETAL DISCOMFORT (back arthritis feels discomfort), VACCINATION SITE PAIN (soreness and injection site) and MUSCULOSKELETAL DISCOMFORT (Knee arthritis feels discomfort). At the time of the report, ARTHRITIS (arthritis is intensified), MUSCULOSKELETAL DISCOMFORT (back arthritis feels discomfort), VACCINATION SITE PAIN (soreness and injection site) and MUSCULOSKELETAL DISCOMFORT (Knee arthritis feels discomfort) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Patient is a 80 y.o. female with history of Parkinsons disease, severe dementia s/p chronic PEG  admitted to the hospital on 9/3/2023 for encephalopathy, hypoxia. Intubated on arrival. Found to be COVID-19 positive. Concern for staph bacteremia, followed by ID with repeat blood cx NGTD. Extubated 9/06/2023. Discharged to home ECF on 9/11/2023 Acute respiratory failure with hypoxia -Intubated in the setting of hypoxia and altered mentation, COVID-19 may also be contributing -Intubated on admit, extubated 9/6/2023.  -Now on RA, treatment of steroids as outlined below   Severe sepsis -Sources include pulmonary or less likely bacteremia with coag negative staph.  She was previously treated with antibiotics, and infectious disease service followed, now off antibiotics   COVID-19 -Reportedly with symptom onset 8/30/2023. Tested positive at ECF on 9/01 -Previously treated at ECF with paxlovid. Held on admit as not able to crush through PEG -Continue decadron 6mg x10 day total   Abnormal CT scan, chest -Recommend repeat CT scan of the chest in 1 month to reevaluate.   Failure to thrive in adult -Severe baseline dementia and Parkinson's, with PEG for nutritional support. Required intubation during hospitalization  -Overall guarded prognosis.   Acute on chronic encephalopathy -Returned to baseline encephalopathy   Parkinsons disease -Continue home med   Hypertension Orthostatic hypotension -Likely exacerbated by agitation, steroid use -Held home florinef -Follow up on BP in 1 week   Hepatic cysts -Likely incidental finding on CT
got a fever of 106 degrees about seven-eight hours after the shot. it got up to 107.2 degrees.  started throwing up about 10 hours after the shot. went to the hospital. was given an iv bag and some anti nausea medicine.  after about a day and a half i felt better.